Policy Positions2020-10-02T14:21:56+00:00
  • Green Band

POLICY POSITIONS

Underwater Biosimilars

IPA supports expanding patient access to biosimilar products, which offer the potential to significantly lower costs for patients and the broader healthcare system. However, this potential is not being fully realized. Today, many physician practices [...]

Categories: Resources|

International Pricing Schemes Will Increase Cost and Adversely Impact Patients

As discussed above, the Infusion Providers Alliance opposes changes to the “buy-and-bill” model that puts patients at risk by unnecessarily increasing the complexity of the supply chain, creating problems with timely access and drug wastage due to changes in therapy regimen and potentially polluting the chain of custody of individual medications for patients.

Categories: Resources|
Go to Top